Document is current
Any future updates will be listed below
-
Authors
Kok, Hing Cheong https://orcid.org/0000-0002-9781-5905
Chang, Anne B.
Fong, Siew Moy
McCallum, Gabrielle B.
Yerkovich, Stephanie T.
Grimwood, Keith
-
Funding
Funding for this research was provided by:
Open access funding enabled and organized by CAUL and its Member Institutions
Charles Darwin University
- License Information
-
More Information
Article History
Accepted: 29 December 2024
First Online: 23 January 2025
Declarations
:
: ABC, GBM, STY, and KG have received grants from the Australian National Health and Medical Research Council (NHMRC) and NHMRC-managed grants (Medical Research Futures Fund). ABC is also an independent data management committee member for clinical trials for Moderna (COVID-19 and Epstein-Barr virus vaccines) and of an unlicensed vaccine (GlaxoSmithKline) and monoclonal antibody (AstraZeneca) and has received fees to the institution for consulting on the study designs for Zambon and Boehringer Ingelheim, airfares for travel from the European Respiratory Society and Boehringer Ingelheim, and personal fees for being an author of two UpToDate chapters that are outside the submitted work. HCK and SMF have no conflicts of interest to disclose.
: Open access funding enabled and organized by CAUL and its Member Institutions. No funds, grants, or other support were received during the preparation of this manuscript. HCK is supported by the Malaysian Ministry of Health and a Charles Darwin International PhD Scholars scholarship, and ABC is supported by an NHMRC L3 fellowship (grant 2025379).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: HCK wrote the first draft of the manuscript, with revisions from KG and ABC. All authors contributed to editing the manuscript and approved the final version.
